- A case report of a patient with a "translocation" RCC treated with pazopanib in the first line2021 | Publication without faculty affiliation
- Pazopanibe2011 | First Faculty of Medicine
- Patient with translocation RCC treated with pazopanib in the first line2021 | Publication without faculty affiliation
- Pazopanib - drug profile2011 | First Faculty of Medicine
- Pazopanib - profile of product2010 | First Faculty of Medicine
- Pazopanib vs. sunitinib in terms of patient preference - results of the PISCES study2012 | Second Faculty of Medicine
- Lasting effect of pazopanib in first-line treatment of renal cell carcinoma2015 | First Faculty of Medicine
- Pazopanib in the treatment of renal cell carcinoma2012 | Second Faculty of Medicine
- Another approach to targeted therapy of patients with metastatic renal carcinoma with progression in treatment with pazopanib:expert assessment by the Czech Cooperative Group for Metastatic Renal Carcinoma2013 | First Faculty of Medicine
- Lékový profil: Pazopanib2013 | Third Faculty of Medicine
- Pazopanib v kombinaci s radioterapií u pacienta s metastatickým karcinomem ledviny2021 | First Faculty of Medicine
- Pazopanib for Metastatic Renal Cell Carcinoma: A Registry-based Analysis of 426 Patients2018 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Central Library of Charles University
- Metformin Use and the Outcome of Metastatic Renal Cell Carcinoma Treated with Sunitinib or Pazopanib2021 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Cabozantinib treatment - case report2020 | First Faculty of Medicine
- Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma: Final Overall Survival Analysis of the Phase 3 PROTECT Trial2021 | First Faculty of Medicine
- Renal cell carcinoma 20152015 | First Faculty of Medicine
- Tyrosine kinase inhibitors in the treatment of metastatic renal cell carcinoma2020 | First Faculty of Medicine
- Systemic treatment of renal cell carcinoma and news in 20142014 | First Faculty of Medicine
- Randomized Phase III Trial of Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma2017 | First Faculty of Medicine
- Impact of Concomitant Cardiovascular Medication on Survival of Metastatic Renal Cell Carcinoma Patients Treated with Sunitinib or Pazopanib in the First Line2021 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Biological treatment of renal cell cancer2012 | First Faculty of Medicine
- Sequential effect of multikinase inhibitors of biological treatment in patient with generalized renal cell carcinoma2010 | First Faculty of Medicine
- Tyrosine kinase inhibitors in the first-line treatment for metastatic nonclear cell renal carcinoma: A retrospective analysis of a national database2019 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Kidney cancer. What is the next step after failure of treatment with angiogenesis inhibitors?2010 | Second Faculty of Medicine
- Systemic therapy for advanced clear cell renal cell carcinoma in 20132014 | Publication without faculty affiliation
- New options for systemic treatment of renal cell cancer2010 | First Faculty of Medicine
- Outcomes of Patients With Long-Term Treatment Response to Vascular Endothelial Growth Factor-Targeted Therapy for Metastatic Renal Cell Cancer2017 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Utilization and efficacy of second-line targeted therapy in metastatic renal cell carcinoma: data from a national registry2017 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové
- Treatment of metastatic renal cell carcinoma in the Czech Republic according to RENIS database2013 | First Faculty of Medicine
- First-line treatment of metastatic renal cell carcinoma2019 | First Faculty of Medicine
